Impact of selection criteria on recruitment in an interventional stroke trial

Cerebrovascular Diseases

Volumn 36, Issue 5-6, 2013, Pages 344-350

  Hotter, Benjamin ^a   Jegzentis, Kati ^a   Steinbrink, Jens ^a   Schmidt, Wolf U ^a   Endres, Matthias ^a   Meisel, Andreas ^a   Haverkamp, Wilhelm ^a   Jungehulsing, Gerhard J ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Department of Psychiatry   (Germany)

Author keywords

Consent; Intervention trial; Methodology; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SCREENING; SELECTION BIAS; VERY ELDERLY; YOUNG ADULT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE FACILITY; RANDOMIZED CONTROLLED TRIAL;

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; HUMANS; INTERVENTION STUDIES; MIDDLE AGED; PATIENT SELECTION; RESEARCH DESIGN; STROKE; YOUNG ADULT;

EID: 84886744391     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000355493     Document Type: Article

References (14)

1. Oude Rengerink K, Opmeer BC, Logtenberg SLM, Hooft L, Bloemenkamp KWM, Haak MC, et al: IMproving PArticipation of patients in Clinical Trials: rationale and design of IMPACT. BMC Med Res Methodol 2010; 10: 85
2. Hagen NA, Wu JS, Stiles CR: A proposed taxonomy of terms to guide the clinical trial recruitment process. J Pain Symptom Manage 2010; 40: 102-110
3. Dani KA, McCormick MT, Muir KW: Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to the use of surrogate markers. Stroke 2008; 39: 2336-2340
4. Demarquay G, Derex L, Nighoghossian N, Adeleine P, Philippeau F, Honnorat J, et al: Ethical issues of informed consent in acute stroke: analysis of the modalities of consent in 56 patients enrolled in urgent therapeutic trials. Cerebrovasc Dis 2005; 19: 65-68 (Pubitemid 40278664)
5. Elkins JS, Khatabi T, Fung L, Rootenberg J, Johnston SC: Recruiting subjects for acute stroke trials: a meta-Analysis. Stroke 2006; 37: 123-128 (Pubitemid 43732059)
6. Breuer L, Blinzler C, Huttner HB, Kiphuth IC, Schwab S, Köhrmann M: Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'. Cerebrovasc Dis 2011; 32: 177-185
7. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP: Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 1994; 12: 1796-1805 (Pubitemid 24349380)
8. Taylor A, Castle A, Merino JG, Hsia A, Kidwell CS, Warach S: Optimizing stroke clinical trial design: estimating the proportion of eligible patients. Stroke 2010; 41: 2236-2238
9. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786 (Pubitemid 41679240)
10. Kane I, Lindley R, Lewis S, Sandercock P, IST-3 Collaborative Group: Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial. Cerebrovasc Dis 2006; 21: 348-352 (Pubitemid 44617299)
11. Rinck GC, van den Bos GA, Kleijnen J, de Haes HJ, Schadé E, Veenhof CH: Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol 1997; 15: 1697-1707 (Pubitemid 27167411)
12. Rose DZ, Kasner SE: Informed consent: the rate-limiting step in acute stroke trials. Front Neurol 2011; 2: 65
13. Petrini C: Informed consent from cognitively impaired persons participating in research trials: comparative law observations. Ann Ist Super Sanita 2011; 47: 353-362
14. Peto R, Baigent C: Trials: the next 50 years -large scale randomised evidence of moderate benefits. BMJ 1998; 317: 1170-1171.